Araceli Naranjo

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Christine E. Brown, Darya Alizadeh, Renate Starr et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Medicine, Immunology, Oncology +17

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

Christine E. Brown, Behnam Badie, Michael E. Barish et al. · Clinical Cancer Research · 2015 · 755 citations

Life Sciences, Immunology, Oncology +17

Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma

Julie R. Park, David DiGiusto, Marilyn L. Slovak et al. · Molecular Therapy · 2007 · 600 citations · Full text

Life Sciences, Immunology, Oncology +16

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Xiuli Wang, Leslie Popplewell, Jamie R. Wagner et al. · Blood · 2016 · 330 citations · Full text

Life Sciences, Hematology, Immunology +14

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Laurence J.N. Cooper, Max S. Topp, Lisa Marie Serrano et al. · Blood · 2003 · 248 citations

Life Sciences, Cancer Biology, Immunology +10